Open AccessMeta-analysis of adjuvant chemotherapy versus surgery alone in T2aN0 stage IB non-small cell lung cancer
Author(s) -
Tianxiang Zhang,
Qiang Guo,
Ye Zhang,
Zhidong Liu,
Shijie Zhou,
Shaofa Xu
Publication year - 2018
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/jcrt.jcrt_862_17
Subject(s) - medicine , meta analysis , cochrane library , lung cancer , relative risk , chemotherapy , oncology , randomized controlled trial , stage (stratigraphy) , randomization , confidence interval , surgery , clinical endpoint , paleontology , biology
Although there is a strong evidence that adjuvant chemotherapy after surgery was effective in Stages II and IIIA patients involved nonsmall cell lung cancer (NSCLC), its eligibility in Stage IB disease has been unknown. Therefore, this meta-analysis was aimed to compare the effects of adjuvant chemotherapy versus surgery alone in patients with Stage IB NSCLC.